Channel

Advanced Lectures in Clinical Immunology & Cellular Therapeutics

@immunology_board

On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry

825subscribers

-2 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID	-1001312848029
Type	Channel
Username	@immunology_board
Created	Between 1 March 2018 and 31 July 2021— estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded	6 August 2026
Last confirmed live	13 August 2026
Measurements held	3
Confirmed unchanged	1 time, most recently 13 August 2026
On Telegram	t.me/immunology_board

Growth

3 measurements spanning 7 days, net -2. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 825–827 and does not start at zero.

Measurement log — every subscribers count we have recorded
Measured (UTC)	Subscribers	Change
13 Aug 2026, 11:25	825	-2
6 Aug 2026, 15:17	827	no change
6 Aug 2026, 09:09	827	first reading

Engagement

20 posts held, back to 9 April 2024 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 13 October 2025. An engagement rate over an empty window would be a number about nothing.

Reaction mix

63 reactions across 18 posts, in 5 distinct kinds. The most used accounts for 41.3% of them.

Every reaction kind recorded on the sample, most used first
Reaction	Count	Share
👏	26	41.3%
❤	21	33.3%
👍	13	20.6%
🔥	2	3.17%
👌	1	1.59%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 18 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 63reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 9 April 2024 to 13 October 2025, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

13 Oct 2025, 16:36 UTC530 views6 reactionsread 6 August 2026

Photo

I’m delighted to share that the book “Cancer and Targeting the Immune System” published by Springer Nature — is now officially available online. I had the honor of authoring Chapter 16, titled “Dendritic Cell–Based Cancer Immunotherapy”, which explores the fascinating interface between immunology and oncology. https://t.me/immunology_board My sincere gratitude goes to Prof. Nima Rezaei for giving me the opportunity…

👏6

Signed Ehsan Shojaeefar

7 Oct 2025, 18:02 UTC467 views2 reactionsread 6 August 2026

https://www.science.org/doi/10.1126/scitranslmed.aaa3032

❤2

Signed M Akbar

7 Oct 2025, 17:58 UTC500 views2 reactionsread 6 August 2026

My research focused on inducing Treg cells in the liver to promote immune tolerance as a therapeutic strategy for Type 1 diabetes—a concept that was still emerging at the time. Today, Treg-based therapies are advancing into clinical practice: In Graft-versus-Host Disease (GvHD), TRX103 therapy is the first-in-class engineered Tr1 cell therapy designed to prevent GvHD in patients undergoing mismatched hematopoietic st…

❤2

Signed M Akbar

7 Oct 2025, 17:58 UTC448 views3 reactionsread 6 August 2026

Photo

A Nobel Moment in Immune Tolerance—A Personal Reflection 🧬 This year’s Nobel Prize in Physiology or Medicine was awarded to Drs. Shimon Sakaguchi, Mary E. Brunkow, and Fred Ramsdell for their pioneering work on immune tolerance and the role of regulatory T cells (Tregs) in preventing autoimmune diseases https://lnkd.in/gBkRx_s8 . Their discoveries have transformed our understanding of how the immune system maintains…

❤3

Signed M Akbar

7 Oct 2025, 10:03 UTC958 views5 reactionsread 6 August 2026

جایزه نوبل فیزیولوژی یا پزشکی ۲۰۲۵ به سه دانشمند ایمنی شناس اختصاص یافت دستاوردها و مسیر تحقیقاتی هر یک ✳️ شیمون ساکاگوچی زمینه تحقیقاتی: ایمونولوژی او در سال ۱۹۹۵ نشان داد که نوعی سلول T تنظیم‌کننده (regulatory T cell یا Treg) وجود دارد که بیان‌کننده CD25 است و در جلوگیری از پاسخ ایمنی علیه بافت‌های خودی نقش دارد. یکی از کارهای کلیدی‌اش این بود که نشان دهد حذف این سلول‌ها باعث بروز بیماری‌های خودایمنی می‌شود. …

❤3👍2

Signed Ehsan Shojaeefar

1 Aug 2025, 19:29 UTC501 views4 reactionsread 6 August 2026

انقلاب علمی در پیشگیری از HIV در ۱۸ ژوئن ۲۰۲۵، FDA برای نخستین‌بار Yeztugo (لناکاپاویر) را به‌عنوان داروی تزریقی پیشگیری پیش از مواجهه (PrEP) تأیید کرد: ✅ فقط دو تزریق در سال ✅ اثربخشی ≥۹۹.۹٪ در مطالعات بزرگ ✅ ویژگی نوآورانه: مهار ساختار کپسید ویروسی و ورود به یک کلاس درمانی جدید جالب اینجاست که لناکاپاویر از دسامبر ۲۰۲۲ برای درمان HIV‌های مقاوم تأیید شده بود و با انجام دو مطالعه کلینیکال فاز III (PURPOSE 1 و 2)، …

👏4

Signed Ehsan Shojaeefar

10 Jul 2025, 15:31 UTCviews —

Advanced Lectures in Clinical Immunology & Cellular Therapeutics pinned Deleted message

9 Jul 2025, 12:06 UTC580 views1 reactionsread 6 August 2026

Forwarded from @ipyafVideo

پیام استاد برجسته پزشکی و فخر سپهر دانش و اخلاق پزشکی ایران و از بنیانگذاران رشته ایمونولوژی و آلرژی نوین ایران ، استاد استادان پروفسور رضا فرید حسینی به مناسبت شروع سمینار علمی و آموزشی فراگیر ایمونولوژی در شاخه های پایه و بالین پزشکی و علوم زیستی پنجشنبه ۱۹ تیرماه ۱۴۰۴ خورشیدی برابر با دهم جولای ۲۰۲۵ میلادی لینک ثبت نام: www.biologyevents.ir بنیاد مکتب پروفسور یلدا: @ipyaf

❤1

Signed Ehsan Shojaeefar

6 Jul 2025, 09:07 UTC≈2,320 views2 reactionsread 6 August 2026

Photo

سمپوزیوم آنلاین «نگاهی به گسترش فزاینده دانش ایمنی‌شناسی در شاخه‌های علوم پزشکی و زیستی» ✍️دبیر علمی جناب پرفسور علیرضا رنجبر استاد ممتاز پزشکی کودکان و نوجوانان، پزشکی مولکولی، ایمونولوژی و آلرژی مولکولی و بالینی، بن، آلمان 🟢محورها: ✳️بررسی کاربردهای علم ایمونولوژی در: ✅ پزشکی و بالین ✅ صنعت دارو و بیوتکنولوژی ✅ درمان‌های نوین سرطان ✅ تولید مثل ✅ معرفی دوره جامع ایمونولوژی به‌صورت رایگان، به‌همراه گواهی معتبر ث…

👍2

Signed Ehsan Shojaeefar

7 May 2025, 17:48 UTC≈14,700 views8 reactionsread 6 August 2026

File

✳️ایمنی شناسی به زبان ساده ✍️دکتر احسان شجاعی فر اگر درک مفاهیم پیچیده ی ایمنی شناسی برای شما دشوار است و از یادگیری ایمنی شناسی نا امید شده اید، این چکیده ی کاربردی و به زبان ساده را بخوانید تا یک نمای کلی از ایمنی شناسی در ذهن شما شکل بگیرد. پس از آن می توانید با مطالعه ی بیشتر و استفاده از متون تخصصی تر دانش خود را در این زمینه بالا ببرید. https://t.me/immunology_board

👏5❤2👍1

Signed Ehsan Shojaeefar

5 May 2025, 03:57 UTC883 viewsread 6 August 2026

Forwarded from @anjoman_iacld16553Photo

◼️انا لله و انا الیه راجعون◼️ درگذشت استاد گرانقدر و فرهیخته دکتر امیر سید علی مهبد همکار دکترای علوم آزمایشگاهی ضایعه‌ای دردناک و جبران ‌ناپذیر برای جامعه علمی و به ‌ویژه خانواده بزرگ آزمایشگاهی کشور است. ایشان عمر پر برکت خود را در راه آموزش، پژوهش و ارتقای سطح علمی نسل جوان صرف نمودند و یاد و نامشان همواره در دل شاگردان و همکارانشان زنده خواهد ماند. ضمن عرض تسلیت به جامعه آزمایشگاهی، دانشجویان، همکاران و خانواده…

Signed M Akbar

22 Apr 2025, 13:12 UTC766 views8 reactionsread 6 August 2026

Forwarded from @fdmagPhoto

تحولی شگرف در درمان پارکینسون: سلول‌های بنیادی امیدی تازه/ دکتر مهسا تهرانی کارشناس علمی فاکس‌نیوز! ⭕️ محققان مرکز سرطان مموریال اسلون کترینگ (MSK) در گامی انقلابی برای درمان پارکینسون، از موفقیت چشمگیر یک روش نوین مبتنی بر سلول‌های بنیادی خبر دادند. 🔴 این رویکرد نوآورانه، که در فاز اول آزمایش‌های بالینی روی ۱۲ بیمار آزمایش شد، با تزریق نورون‌های تولیدکننده دوپامین (ساخته‌شده از سلول‌های بنیادی اهدایی) به مغز بیمار…

👏8

Signed M Akbar

Showing the 12 most recent of 20 posts we hold for @immunology_board. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Citation-graph rank

Citation-graph rank — 1,108,590 of 1,481,217entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Republishes

Channels on the register whose posts this channel has forwarded.

TREND IMMUNOLOGY
@Trend_Immunology · 4693 posts کانال رسمی انجمن دکترای علوم آزمایشگاهی
@anjoman_iacld16553 · 2,6641 post رسانه خبری غذا و دارو
@fdmag · 11,0571 post Cancer Genetics 🎗️🧬
@icgcongress · 1,1881 post بنیاد مکتب پروفسور یلدا
@ipyaf · 8941 post

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

TREND IMMUNOLOGY
@Trend_Immunology · 46916 posts

Names

Channels on the register whose handles appear in this channel's posts.

USERN
@usern_net · 11,5495 posts Sababiomedicals | فلوسایتومتری
@SabaFlow · 8,2653 posts TREND IMMUNOLOGY
@Trend_Immunology · 4693 posts Username Bids📢
@UsernameBidsChannel · 562 posts رسانه خبری غذا و دارو
@fdmag · 11,0571 post Cancer Genetics 🎗️🧬
@icgcongress · 1,1881 post بنیاد مکتب پروفسور یلدا
@ipyaf · 8941 post

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 13 August 2026 — this entry's latest reading, not the date you are reading this.

“Advanced Lectures in Clinical Immunology & Cellular Therapeutics” (@immunology_board), 825 subscribers as measured 13 August 2026. Telegram Register, tgregister.com/channel/immunology_board.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.